Clinical trial
Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing
NCT05699265 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Phase
- Observational
- Overall status
- Terminated
- Start date
- February 1, 2023
- Completion date
- April 1, 2025
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.